Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months

Mise à jour : Il y a 4 ans
Référence : NCT00755833

Femme et Homme

  • | Pays :
  • Slovenia
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This study is conducted in Europe. The aim of this observational study is to evaluate the blood glucose control when using NovoMix® 50 up to 12 months after initiation subjects with type 2 diabetes currently on a therapy with human biphasic insulin. An additional objective is also to observe the different regimes of starting and maintaining the treatment with NovoMix® 50 during one year.


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 2

Liens